The reperfusion syndrome: Have we made any progress?
Michael Ramsay – 26 March 2008
Correlation between the liver temperature employed during machine perfusion and reperfusion damage: Role of Ca2+
Mariapia Vairetti, Andrea Ferrigno, Vittoria Rizzo, Eleonora Boncompagni, Amedeo Carraro, Enrico Gringeri, Gloria Milanesi, Sergio Barni, Isabel Freitas, Umberto Cillo – 26 March 2008 – This study compares the effects of machine perfusion (MP) at different temperatures with simple cold storage. In addition, the role of Ca2+ levels in the MP medium was evaluated. For MP, rat livers were perfused for 6 hours with Krebs‐Henseleit (KH) solution (with 1.25 or 2.5 mM CaCl2) at 4°C, 10°C, 20°C, 25°C, 30°C, or 37°C.
Reply: Prophylactic variceal ligation is not recommended for patients awaiting live donor liver transplant
Lorenzo Norberto, Andrew Burroughs, Lino Polese – 26 March 2008
Audiometric changes in patients undergoing liver transplantation using distinct immunosuppressive protocols
Maria Elena Fortes, Cláudio Augusto Marroni, Pedro Luis Coser, Carlos Abaeté de los Santos – 26 March 2008 – The aim of the study was to disclose a possible association of hearing defects with the use of either cyclosporin (CyA) or tacrolimus (FK‐506) in patients undergoing liver transplantation (LT). Pure‐tone audiometry (PTA) was performed in the same 42 patients before and after LT. Audiometric frequencies recorded ranged from 250 to 8000 Hz. Patients were divided into 2 groups according to the use of CyA (n = 18) or FK‐506 (n = 24).
Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long‐term follow‐up after liver transplantation
Ayako Tsuchiya, Masahide Yazaki, Fuyuki Kametani, Yo‐ichi Takei, Shu‐ichi Ikeda – 26 March 2008 – To elucidate whether the amount of tissue‐deposited amyloid in familial amyloid polyneuropathy (FAP) patients decreases or increases over the long‐term course after liver transplantation (LT), we examined changes in histopathological and biochemical characteristics of abdominal fat amyloid in the transplanted patients with a postoperative history of more than 10 years.
Understanding quality of life for children after liver transplantation: A work in progress
Vicky Lee Ng, Anthony R. Otley – 26 March 2008
Prophylactic variceal ligation is not recommended for patients awaiting live donor liver transplant
Chun‐Tao Wai, Kang‐Hoe Lee, Kai‐Chah Tan – 26 March 2008
Reply:
Yaakov Nahmias, Martin L. Yarmush, Raymond T. Chung – 26 March 2008
Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system
Michael Adler, Filip De Pauw, Pierre Vereerstraeten, Agnese Fancello, Jan Lerut, Peter Starkel, Hans Van Vlierberghe, Roberto Troisi, Vincent Donckier, Olivier Detry, Jean Delwaide, Peter Michielsen, Thierry Chapelle, Jacques Pirenne, Frederik Nevens – 26 March 2008 – Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation, the rules governing priority and access to the waiting list are not well defined.
Postischemic treatment by trans‐resveratrol in rat liver ischemia‐reperfusion: A possible strategy in liver surgery
Sahar Hassan‐Khabbar, Charles‐Henry Cottart, Dominique Wendum, Françoise Vibert, Jean‐Pierre Clot, Jean‐François Savouret, Marc Conti, Valérie Nivet‐Antoine – 26 March 2008 – Liver ischemia‐reperfusion (I/R) injury occurs in many clinical conditions, including liver surgery and transplantation. Oxygen free radicals generated during I/R reduce endogenous antioxidant systems and contribute to hepatic injury. trans‐Resveratrol (trans‐3,5,4′‐trihydroxystilbene) is reported to have antioxidant properties. We investigated the effect of trans‐resveratrol on liver injury induced by I/R.